TrialNeurology2026

Intrathecal Mesenchymal Stem Cells in Progressive Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial (SMART-MS).

Christopher Elnan Kvistad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.